BJDX

Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. (BJDX) has 1 SEC Form 4 filing (2 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 13, 2026.

  • Industry:Medical - Devices
  • CEO:Indranil Dey
  • Employees:6
  • HQ:Acton, MA, US
  • IPO:2021-11-10

Insider Buying

$97K

reported purchases (SEC code P)

Insider Selling

$49K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$1.4M

latest known value

Source
Purchase$97KJul 13SEC ↗
Sale$49KJul 13SEC ↗

Related companies

Bluejay Diagnostics, Inc. is in the Healthcare sector.